Join OHE for two exciting seminars, one on MCDA and the other on shifts in investment in R&D. OHE invites you to join us for two lunchtime seminars in early December. On 7 December, Prof Larry Philips of LSE will…
Join OHE for two exciting seminars, one on MCDA and the other on shifts in investment in R&D.
OHE invites you to join us for two lunchtime seminars in early December.
On 7 December, Prof Larry Philips of LSE will report on the development of MCDA by the EMA’s Benefit-Risk Project, an effort he has been leading. Using case studies, he will explain how MCDA can be used to improve both the quality and transparency of decision making. Click here for more information and to register.
On 8 December, Prof Massimo Riccaboni, University of Trento, will present the results of the groundbreaking analysis he published recently on the relationship between shifts in investment to more difficult areas of science and productivity in R&D in the pharmaceutical industry. He also will report results comparing productivity of US- and European-based companies, discussing the implications for EU R&D and industrial policy. Click here for more information and to register.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!